Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.43 |
| ▸ | COMT | P21964 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8140807 | 0.78 | LMNA (0.57) | NPSR1TSHRALDH1A1SMN1; SMN2HSD17B3 | |
| SCHEMBL11825886 | 0.78 | NPSR1 (0.41) | NPSR1TSHRALDH1A1CYP2D6HSD17B3 | |
| SCHEMBL24124865 | 0.76 | LMNA (0.40) | NPSR1ALDH1A1SMN1; SMN2LMNAKCNN4 | |
| SCHEMBL4415354 | 0.75 | SMN1; SMN2 (0.57) | ALDH1A1SMN1; SMN2CYP2D6CYP2C9NOTUM | |
| SCHEMBL7688831 | 0.75 | SMN1; SMN2 (0.57) | ALDH1A1SMN1; SMN2CYP2D6CYP2C9NOTUM | |
| SCHEMBL21169559 | 0.74 | TSHR (0.53) | NPSR1TSHRALDH1A1GFERLMNA | |
| SCHEMBL6858952 | 0.74 | ALDH1A1 (0.53) | NPSR1TSHRALDH1A1SMN1; SMN2HSD17B3 | |
| SCHEMBL10066394 | 0.74 | NPSR1 (0.63) | NPSR1TSHRALDH1A1SMN1; SMN2GFER | |
| SCHEMBL24124853 | 0.73 | LMNA (0.70) | NPSR1TSHRALDH1A1SMN1; SMN2CYP2C9 | |
| SCHEMBL627482 | 0.72 | MAOA (0.58) | TSHRALDH1A1SMN1; SMN2CYP2D6GFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230339916-A1 | PLANT GROWTH REGULATOR COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2023-10-26 | — | — | US | disclosed |
| US-20230339916-A1 | PLANT GROWTH REGULATOR COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339916-A1 | PLANT GROWTH REGULATOR COMPOUNDS | MYB, TOE1, SUB1 | NPSR1 1062/4885TSHR 671/4885ALDH1A1 1741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.